FTY720: From bench to bedside

Transplantation Proceedings

Volumn 36, Issue 2 SUPPL., 2004, Pages S531-S543

  Kahan, B D ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; EVEROLIMUS; FINGOLIMOD; IMMUNOSUPPRESSIVE AGENT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; RAPAMYCIN; TACROLIMUS;

ANGIOGENESIS; ANTIBODY PRODUCTION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BRONCHOSPASM; CATALYSIS; CELL DAMAGE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL PROTECTION; CELL STIMULATION; CHRONOTROPISM; CLINICAL TRIAL; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; DRUG POTENCY; DRUG POTENTIATION; DRUG SOLUBILITY; DRUG TOLERANCE; ENZYME ACTIVATION; ENZYME ACTIVITY; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HUMAN; HYPERPLASIA; LYMPHOCYTE DEPLETION; LYMPHOCYTOPENIA; MUSCLE HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SIDE EFFECT; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TOXICITY; XENOTRANSPLANTATION;

ISARIA SINCLAIRII;

EID: 1642336345     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.01.092     Document Type: Article

References (83)

1. Fujita T., Inoue K., Yamamoto S., et al. Fungal metabolites. Part 11. A potent immunosuppressive activity found in Isaria sinclairii metabolite. J Antibiotics. 47:1994;208.
2. Hong J.C., Kahan B.D. Two paradigms for new immunosuppressive strategies in organ transplantation. Curr Opin Organ Transplant. 3:1998;175.
3. Adachi K., Kahora T., Nakao N., et al. Design, synthesis, and structure-activity relationships of 2-substituted-2-amino-1,3-propanediols discovery of a novel immunosuppressant, FTY720. Bio Med Chem Lett. 5:1995;853.
4. Mandala S., Hajdu R., Bergstrom J., et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science. 296:2002;346.
5. Brinkmann V., Davis M.D., Heise C.E., et al. The immune modulator, FTY720, targets sphingosine-1-phosphate receptors. J Biol Chem. 277:2002;21453.
6. Hla T., Lee M.J., Ancellin N., et al. Lysophospholipids-receptor revelations. Science. 294:2001;1875.
7. Hla T. Sphingosine 1-phosphate receptors. Prostaglandins Other Lipid Mediat. 64:2001;135.
8. Idzko M., Panther E., Corinti S., et al. Sphingosine 1-phosphate induces chemotaxis of immature and modulates cytokine-release in mature human dendritic cells for emergence of Th2 immune responses. FASEB J. 16:2002;625.
9. Chiba K., Hoshino Y., Suzuki C., et al. FTY720, A novel immunosuppressant possessing unique mechanisms. I. Prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rats. Transplant Proc. 28:1996;1056.
10. Wang M.E., Tejpal N., Qu X., et al. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine or sirolimus. Transplantation. 65:1998;899.
11. Chiba K., Yanagawa Y., Masubuchi Y., et al. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J Immunol. 160:1998;5037.
12. Miyake Y., Kozutsumi Y., Nakamura S., et al. Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-I/Myriocin. Biochem Biophys Research Comm. 211:1995;396.
13. Suzuki S., Enosawa S., Kakefuda T., et al. A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation. Transplantation. 61:1996;200.
14. Pinschewer D.D., Ochsenbein A.F., Odermatt B., et al. FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory. J Immunol. 164:2000;5761.
15. Chiba K., Yanagawa Y., Kataoka H., et al. FTY720, a novel immunosuppressant, induces sequestration of circulating lymphocytes by acceleration of lymphocyte homing. Transplant Proc. 31:1999;1230.
16. Yanagawa Y., Sugahara K., Kataoka H., et al. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo. J Immunol. 160:1998;5493.
17. Kahan B.D. FTY720 a new immunosuppressive agent with novel mechanism(s) of action. Transplant Proc. 30:1998;2210.
18. Shimizu C., Li X., Kimura M., et al. A novel immunosuppressant, FTY720, increases the efficiency of a superantigen-induced peripheral T-cell deletion whilst inhibiting negative selection in the thymus. Immunology. 94:1998;503.
19. Suzuki S., Li X.K., Shinomiya T., et al. The in vivo induction of lymphocyte apoptosis in MRL-1pr/1pr mice treated with FTY720. Clin Exp Immunol. 107:1997;103.
20. Suzuki S., Li X.K., Enosawa S., et al. A new immunosuppressant, FTY720, induces bcl-2-associated apoptotic cell death in human lymphocytes. Immunology. 89:1996;518.
21. Li X.K., Shinomiya T., Enosawa S., et al. Induction of lymphocyte apoptosis by a novel immunosuppressant FTY720 relation with FAS, Bcl-2 and Bax expression. Transplant Proc. 29:1997;1267.
22. Fujino M., Li X.K., Guo L., et al. T-cell apoptosis triggered by FTY720 via mitochondrial pathway. Transplant Proc. 33:2001;3084.
23. Nagahara Y., Ikekita M., Shinomiya T. Immunosuppressant FTY720 induces apoptosis by direct induction of permeability transition and release of cytochrome c from mitochondria. J Immunol. 165:2000;3250.
24. Ohta H., Sweeney E.A., Masamune A., et al. Induction of apoptosis by sphingosine in human leukemic HL-60 cells a possible endogenous modulator of apoptotic DNA fragmentation occurring during phorbol ester-induced differentiation. Cancer Res. 55:1995;691.
25. Shinomiya T., Li X.K., Amemiya H., et al. An immunosuppressive agent, FTY720, increases intracellular concentration of calcium ion and induces apoptosis of HL-60. Immunology. 91:1997;594.
26. Matsuda T., Nakajima H., Fujiwara I., et al. Caspase requirement for the apoptotic death of WR19L-induced by FTY720. Transplant Proc. 30:1998;2355.
27. Matsuda S., Minowa A., Suzuki S., et al. Differential activation of c-Jun NH2-terminal kinase and p38 pathways during FTY720-induced apoptosis of T lymphocytes that is suppressed by the extracellular signal-regulated kinase pathway. J Immunol. 162:1999;3321.
28. Yanagawa Y., Hoshino Y., Kataoka H., et al. FTY720, a novel immunosuppressant, prolongs rat skin allograft survival by decreasing T-cell infiltration into grafts. Transplant Proc. 31:1999;1227.
29. Li X.K., Enosawa S., Kakefuda T., et al. FTY720, a novel immunosuppressive agent, enhances upregulation of the cell adhesion molecular ICAM-1 in TNF-alpha treated human umbilical vein endothelial cells. Transplant Proc. 29:1997;1265.
30. Yanagawa Y., Masubuchi Y., Chiba K. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats, III. Increase in frequency of CD62L-positive T cells in Peyer's patches by FTY720-induced lymphocyte homing. Immunology. 95:1998;591.
31. Bai Y., Liu J., Wang Y., et al. L-selectin-dependent lymphoid occupancy is required to induce alloantigen-specific tolerance. J Immunol. 168:2002;1579.
32. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration The multistep paradigm. Cell. 76:1994;301.
33. Chen S., Bacon K.B., Garcia G., et al. FTY720, a novel transplantation drug, modulates lymphocyte migratory responses to chemokines. Transplant Proc. 33:2001;3057.
34. Kahan B.D. FTY720 a new dimension in transplantation. Transplant Proc. 33:2001;3081.
35. Luther S.A., Bidgol A., Hargreaves D.C., et al. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J Immunol. 169:2002;424.
36. Henning G., Ohl L., Junt T., et al. CC chemokine receptor 7-dependent and -independent pathways for lymphocyte homing modulation by FTY720. J Exp Med. 194:2001;1875.
37. Gunn M.D., Kyuwa S., Tam C., et al. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med. 189:1999;451.
38. Luther S.A., Tang H.L., Hyman P.L., et al. Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc Natl Acad Sci USA. 97:2000;12694.
39. Nakano H., Mori S., Yonekawa H., et al. A novel mutant gene involved in T-lymphocyte-specific homing into peripheral lymphoid organs on mouse chromosome 4. Blood. 91:1998;2886.
40. Graeler M., Shankar G., Goetzl E.J. Cutting edge suppression of T cell chemotaxis by sphingosine 1-phosphate. J Immunol. 169:2002;4084.
41. Luo Z.J., Tanaka T., Kimura F., et al. Analysis of the mode of action of a novel immunosuppressant FTY720 in mice. Immunopharmacology. 41:1999;199.
42. Nagahara Y., Eosawa S., Ikekita M., et al. Evidence that FTY720 induces T cell apoptosis in vivo. Immunopharmacology. 48:2000;75.
43. Tedesco-Silva H, Mourad G, Kahan BD, et al. FTY720 - a novel immunomodulator - efficacy and safety results from the first phase 2a study in de novo renal transplantation. Transplantation (in press).
44. Troncoso P., Stepkowski S.M., Wang M.E., et al. Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine. Transplantation. 67:1999;145.
45. Tamura A., Li X.K., Funeshima N., et al. Immunosuppressive therapy using FTY720 combined with tacrolimus in rat liver transplantation. Surgery. 127:2000;47.
46. Mitsusada M., Suzuki S., Kobayashi E., et al. Prevention of graft rejection and graft-versus-host reaction by a novel immunosuppressant, FTY720, in rat small bowel transplantation. Transpl Int. 10:1997;343.
47. Chueh S.C., Tian L., Wang M., et al. Induction of tolerance toward rat cardiac allografts by treatment with allochimeric class I MHC antigen and FTY720. Transplantation. 64:1997;1407.
48. Suzuki K., Kazui T., Kawabe A., et al. Immunosuppressive effect of FTY 720 on rat pancreas allograft. Transplant Proc. 30:1998;3417.
49. Xu M., Pirenne J., Antoniou S., et al. FTY720 compares with FK 506 as rescue therapy in rat heterotopic cardiac transplantation. Transplant Proc. 30:1998;2221.
50. Xu M., Pirenne J., Antoniou E.A., et al. Effect of peritransplant FTY720 alone or in combination with post-transplant tacrolimus in a rat model of cardiac allotransplantation. Transpl Int. 11:1998;288.
51. Kunikata S., Nagano T., Nishioka T., et al. Immunosuppressive action of FTY720 for renal allograft a rat model. Transplant Proc. 31:1999;1157.
52. Quesniaux V., Menninger K., Audet M., et al. FTY-720 is efficacious in monkey kidney transplantation. Transplant Proc. 33:2001;2374.
53. Stepkowski S.M., Wang M., Qu X., et al. Synergistic interaction of FTY720 with cyclosporine or sirolimus to prolong heart allograft survival. Transplant Proc. 30:1998;2214.
54. Fang Y., Vilella-Bach M., Bachmann R., et al. Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science. 294:2001;1942.
55. Hoshino Y., Yanagawa Y., Ohtsuki M., et al. FTY720, a novel immunosuppressant, shows a synergistic effect in combination with FK 506 in rat allograft models. Transplant Proc. 31:1999;1224.
56. Nikolova Z., Hof A., Baumlin Y., et al. The peripheral lymphocyte count predicts graft survival in DA to Lewis heterotopic heart transplantation treated with FTY720 and SDZ RAD. Transpl Immunol. 8:2000;115.
57. Ohba M., Li X.K., Kita Y., et al. Long-term graft acceptance in rat heart transplantation by CTLA4Ig gene transfection combined with FTY720 treatment. World J Surg. 25:2001;391.
58. Kita Y., Li X.K., Funeshima N., et al. Prolonged graft survival induced by CTLA4IG-gene transfection combined with FTY720 administration in rat heart grafting. Transplant Proc. 31:1999;2787.
59. Miyata Y., Ohdan H., Noriyuki T., et al. Prolongation of concordant xenograft survival by treatment with FTY720. Transplant Proc. 30:1998;4163.
60. Fukuda Y., Ohdan H., Miyata Y., et al. Effect of FTY720 on immunoregulation in concordant xenotransplantation. Transpl Int. 11:1998;S461.
61. Fu F., Hu S., Li S., et al. FTY720, a novel immunosuppressive agent with insulinotropic activity, prolongs graft survival in a mouse islet transplantation model. Transplant Proc. 33:2001;672.
62. Zhang J., Song Z., Wijkstrom M., et al. FTY720 in combination with CsA inhibits islet xenograft rejection a study in the pig-to-rat model. Transplant Proc. 32:2000;1017.
63. Matsuura M., Imayoshi T., Chiba K., et al. Effect of FTY720, a novel immunosuppressant, on adjuvant-induced arthritis in rats. Inflamm Res. 49:2000;404.
64. Matsuura M., Imayoshi T., Okumoto T. Effect of FTY720, a novel immunosuppressant, on adjuvant- and collagen-induced arthritis in rats. Int J Immunopharmacol. 22:2000;323.
65. Kurose S., Ikeda E., Tokiwa M., et al. Effects of FTY720, a novel immunosuppressant, on experimental autoimmune uveoretinitis in rats. Exp Eye Res. 70:2000;7.
66. Hozumi Y., Kobayashi E., Miyata M., et al. Immunotherapy for experimental rat autoimmune thyroiditis using a novel immunosuppressant, FTY720. Life Sci. 65:1999;1739.
67. Kitabayashi H., Isobe M., Watanabe N., et al. FTY720 prevents development of experimental autoimmune myocarditis through reduction of circulating lymphocytes. J Cardiovasc Pharmacol. 35:2000;410.
68. Miyamoto T., Matsumori A., Hwang M.W., et al. Therapeutic effects of FTY720, a new immunosuppressive agent, in a murine model of acute viral myocarditis. J Am Coll Cardiol. 37:2001;1713.
69. Okazaki H., Hirata D., Kamimura T., et al. Effects of FTY720 in MRL-lpr/lpr mice therapeutic potential in systemic lupus erythematosus. J Rheumatol. 29:2002;707.
70. Fu F., Hu S., Deleo J., et al. Long-term islet graft survival in streptozotocin- and autoimmune- induced diabetes models by immunosuppressive and potential insulinotropic agent FTY720. Transplantation. 73:2002;1425.
71. Tawadrous M.N., Mabuchi A., Zimmermann A., et al. Effects of immunosuppressant FTY720 on renal and hepatic hemodynamics in the rat. Transplantation. 74:2002;602.
72. Bers D.M. Cardiac excitation-contraction coupling. Nature. 415:2002;198.
73. Takahara S., Tanaka T., Wang J.D., et al. FTY720 prevents ischemic/reperfusion injury in murine kidney [Abstract 400]. Am J Transplantation. 1:2001;255.
74. Troncoso P., Ortiz M., Martinez L., et al. FTY720 prevents ischemic reperfusion damage in rat kidneys. Transplant Proc. 33:2001;857.
75. Anselmo D.M., Amersi F.F., Shen X.D., et al. FTY720 pretreatment reduces warm hepatic ischemia reperfusion injury through inhibition of T-lymphocyte infiltration. Am J Transplant. 2:2002;843.
76. Man K., Ng K.T.P., Lee T.K.W., et al. FTY720 attenuates ischemia-reperfusion injury in normal and cirrhotic rat liver [Abstract 488]. Am J Transplant. 3:2003;276.
77. Mizuta K., Ohmori M., Miyashita F., et al. Effect of pretreatment with FTY720 and cyclosporin on ischaemia-reperfusion injury of the liver in rats. J Pharm Pharmacol. 51:1999;1423.
78. Hwang M.W., Matsumori A., Furukawa Y., et al. FTY720, a new immunosuppressant, promotes long-term graft survival and inhibits the progression of graft coronary artery disease in a murine model of cardiac transplantation. Circulation. 100:1999;1322.
79. Chueh S., Chen J., Chen J., et al. FTY720 prevents chronic rejection of rat heterotopic cardiac allografts. Transplant Proc. 33:2001;542.
80. Koshiba T., Van Damme B., Rutgeerts O., et al. FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A. Transplantation. 75:2003;945.
81. Nikolova Z., Hof A., Rudin M., et al. Prevention of graft vessel disease by combined FTY720/cyclosporine. A treatment in a rat carotid artery transplantation model. Transplantation. 69:2000;2525.
82. Nikolova Z., Hof A., Baumlin Y., et al. Efficacy of SDZ RAD compared with CsA monotherapy and combined Rad/FTY720 treatment in a murine cardiac allotransplantation model. Transpl Immunol. 9:2001;43.
83. Blaha P., Bigenzahn S., Koporc Z., et al. The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade. Blood. 101:2003;2886.